<DOC>
	<DOCNO>NCT01404429</DOCNO>
	<brief_summary>To use different start dos methotrexate ( 7.5 mg per week ) versus 15 mg per week patient rheumatoid arthritis , follow similar hiking dose ( 2.5 mg per 2 week , till max 25 mg per week ) . To look effect efficacy ( speed efficacy ) versus adverse effect . Hypothesis : There difference adverse effect , good faster control disease start high methotrexate dose</brief_summary>
	<brief_title>Study Two Different Starting Doses Methotrexate When Starting Treatment Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Patients rheumatoid arthritis fulfil ACR 1987 criterion Between 18 year 65 year age Having active disease Disease activity score ( 28 joint ) DAS283 5.1 Not methotrexate last 2 month Permitted corticosteroid dosage stable least 1 week randomization corticosteroid dosage le 10 mg/day Permitted disease modify antirheumatic drug ( DMARD ) like sulfasalazine , leflunomide hydroxychloroquine , dosages stable least 2 week randomization Pregnant/Breastfeeding Ongoing/Recent treatment methotrexate ( 2 month ) Chronic liver disease Renal failure Any leucopenia thrombocytopenia Breastfeeding Desirous pregnancy next 6 month Known Hepatitis B C positive Known clinically relevant chronic lung disease : ILD Tuberculosis active infection Known HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>Active</keyword>
</DOC>